Mirtha Legrand Recovering Well, Set to Return to TV Next Week
Translated from Spanish, summarized and contextualized by DistantNews.
TLDR
- Legendary Argentine television host Mirtha Legrand is recovering well from bronchitis, easing concerns about her health.
- A recent photo shared by her assistant, Débora D’Amato, showed Legrand in excellent condition, dispelling rumors of a serious decline.
- Legrand is expected to return to her popular television show, 'La noche de Mirtha,' next week.
The beloved icon of Argentine television, Mirtha Legrand, is on the mend, bringing much-needed relief to her legion of devoted fans. After a period of concern due to a bout of bronchitis that led to medical advice for rest and antibiotic treatment, recent developments have painted a much brighter picture of 'La Chiqui's' health.
The circulation of a photograph, shared by her long-time assistant Débora D’Amato, has been instrumental in quelling anxieties. The image, reportedly taken during the birthday celebration of Legrand's assistant Elvira Guaraz, depicts the 99-year-old host looking remarkably well. D’Amato's accompanying message on X (formerly Twitter) confirmed the positive outlook, stating that Legrand is not only recovered but 'better than ever' and set to resume her television duties next week.
This news has been met with widespread joy and relief across social media platforms. Messages of affection, well wishes, and excitement for her return have flooded in, underscoring Legrand's enduring popularity and her significant place in Argentine culture. Her ability to bounce back with such vigor reassures viewers that the 'queen of talk shows' is ready to grace their screens once again, continuing her unparalleled legacy in broadcasting.
Yesterday was Elvira's birthday and Mirtha Legrand, the legend, is not only recovered: she is better than ever! What a joy! She resumes TV next week.
Originally published by La Nación in Spanish. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.